Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Drug Resistance Updates | journal | 4.010 Q1 | 132 | 27 | 52 | 6312 | 868 | 52 | 17.80 | 233.78 | |
2 | Pharmacology and Therapeutics | journal | 3.461 Q1 | 233 | 151 | 450 | 30790 | 5501 | 450 | 11.71 | 203.91 | |
3 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | |
4 | Drug Metabolism Reviews | journal | 1.023 Q2 | 108 | 27 | 78 | 3586 | 437 | 78 | 4.53 | 132.81 | |
5 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.106 Q4 | 1 | 6 | 7 | 732 | 0 | 3 | 0.00 | 122.00 | |
6 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 13 | 47 | 1511 | 145 | 45 | 3.38 | 116.23 | ||
7 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.205 Q3 | 2 | 7 | 7 | 778 | 4 | 2 | 0.57 | 111.14 | |
8 | Expert Opinion on Emerging Drugs | journal | 0.975 Q2 | 54 | 41 | 78 | 4420 | 273 | 76 | 3.70 | 107.80 | |
9 | Advanced Therapeutics | journal | 0.125 Q4 | 39 | 78 | 155 | 8196 | 862 | 152 | 5.56 | 105.08 | |
10 | Cochrane Database of Systematic Reviews | journal | 1.319 Q1 | 327 | 924 | 3373 | 96550 | 12593 | 3317 | 3.44 | 104.49 | |
11 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q2 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | |
12 | Cancer Drug Resistance | journal | 24 | 71 | 102 | 6698 | 243 | 102 | 2.38 | 94.34 | ||
13 | Expert Opinion on Orphan Drugs | journal | 0.237 Q3 | 27 | 49 | 228 | 4388 | 166 | 216 | 0.68 | 89.55 | |
14 | Neurotherapeutics | journal | 2.496 Q1 | 136 | 154 | 292 | 13488 | 2091 | 270 | 6.61 | 87.58 | |
15 | Expert Review of Clinical Pharmacology | journal | 1.014 Q2 | 60 | 124 | 360 | 10783 | 1396 | 317 | 4.33 | 86.96 | |
16 | Expert Review of Neurotherapeutics | journal | 1.187 Q1 | 98 | 121 | 316 | 10497 | 1273 | 271 | 4.09 | 86.75 | |
17 | Frontiers in Medical Technology | journal | 15 | 29 | 3 | 2497 | 2 | 0 | 0.67 | 86.10 | ||
18 | Journal of Biomedical Science | journal | 2.182 Q1 | 110 | 100 | 278 | 8431 | 2291 | 278 | 7.92 | 84.31 | |
19 | Expert Opinion on Investigational Drugs | journal | 1.410 Q1 | 117 | 132 | 336 | 11059 | 1672 | 321 | 5.10 | 83.78 | |
20 | CNS Drugs | journal | 1.565 Q1 | 129 | 87 | 269 | 7063 | 1411 | 258 | 4.83 | 81.18 | |
21 | Paediatric Drugs | journal | 0.750 Q2 | 70 | 56 | 155 | 4510 | 472 | 149 | 2.92 | 80.54 | |
22 | Expert Review of Anticancer Therapy | journal | 1.209 Q1 | 85 | 118 | 348 | 8783 | 1361 | 312 | 3.81 | 74.43 | |
23 | PharmaNutrition | journal | 0.548 Q3 | 30 | 57 | 68 | 4231 | 249 | 68 | 2.28 | 74.23 | |
24 | Expert Opinion on Pharmacotherapy | journal | 0.873 Q2 | 93 | 230 | 647 | 16897 | 1968 | 568 | 3.01 | 73.47 | |
25 | Journal of Cardiovascular Development and Disease | journal | 32 | 59 | 122 | 4208 | 436 | 118 | 3.65 | 71.32 | ||
26 | BioDrugs | journal | 1.919 Q1 | 79 | 62 | 166 | 4406 | 981 | 155 | 4.90 | 71.06 | |
27 | Expert Opinion on Drug Safety | journal | 1.086 Q1 | 90 | 155 | 386 | 10932 | 1524 | 364 | 3.90 | 70.53 | |
28 | PPAR Research | journal | 1.164 Q1 | 59 | 29 | 58 | 2019 | 248 | 57 | 3.70 | 69.62 | |
29 | Biologics: Targets and Therapy | journal | 0.948 Q2 | 47 | 12 | 49 | 833 | 192 | 49 | 4.50 | 69.42 | |
30 | Current Treatment Options in Oncology | journal | 1.457 Q1 | 66 | 97 | 242 | 6481 | 1179 | 240 | 4.83 | 66.81 | |
31 | Current Cardiovascular Risk Reports | journal | 0.285 Q3 | 34 | 25 | 106 | 1660 | 69 | 106 | 0.74 | 66.40 | |
32 | Frontiers in Pharmacology | journal | 1.384 Q1 | 154 | 2200 | 3969 | 145595 | 22327 | 3901 | 5.45 | 66.18 | |
33 | ACS Pharmacology and Translational Science | journal | 2.271 Q1 | 36 | 132 | 64 | 8523 | 223 | 56 | 3.48 | 64.57 | |
34 | Inflammopharmacology | journal | 0.945 Q2 | 68 | 122 | 303 | 7731 | 1325 | 302 | 4.13 | 63.37 | |
35 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 51 | 308 | 3211 | 1584 | 299 | 4.77 | 62.96 | |
36 | Vaccines | journal | 1.296 Q1 | 85 | 782 | 345 | 49214 | 1510 | 334 | 4.18 | 62.93 | |
37 | Experimental and Clinical Psychopharmacology | journal | 1.066 Q2 | 101 | 68 | 192 | 4274 | 492 | 190 | 2.54 | 62.85 | |
38 | Therapeutic Advances in Psychopharmacology | journal | 43 | 54 | 92 | 3390 | 345 | 79 | 4.27 | 62.78 | ||
39 | ADMET and DMPK | journal | 0.309 Q3 | 21 | 25 | 66 | 1556 | 92 | 61 | 1.36 | 62.24 | |
40 | Current Drug Therapy | journal | 0.174 Q4 | 20 | 53 | 51 | 3296 | 31 | 49 | 0.54 | 62.19 | |
41 | European Neuropsychopharmacology | journal | 1.603 Q1 | 130 | 151 | 380 | 9269 | 1573 | 368 | 3.70 | 61.38 | |
42 | Journal of Psychopharmacology | journal | 1.333 Q1 | 135 | 143 | 444 | 8729 | 1717 | 428 | 3.69 | 61.04 | |
43 | Journal of Experimental Pharmacology | journal | 0.555 Q3 | 23 | 57 | 34 | 3466 | 122 | 34 | 2.36 | 60.81 | |
44 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.071 Q1 | 47 | 52 | 162 | 3156 | 646 | 160 | 4.07 | 60.69 | |
45 | Methods in Pharmacology and Toxicology | book series | 0.125 Q4 | 14 | 47 | 169 | 2846 | 109 | 1 | 0.77 | 60.55 | |
46 | Antibiotics | journal | 0.960 Q2 | 77 | 928 | 416 | 54250 | 1995 | 408 | 4.60 | 58.46 | |
47 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 12 | 46 | 696 | 71 | 39 | 1.91 | 58.00 | ||
48 | Drugs | journal | 2.022 Q1 | 188 | 170 | 501 | 9796 | 3960 | 491 | 7.95 | 57.62 | |
49 | Drug Target Insights | journal | 0.297 Q3 | 16 | 5 | 10 | 283 | 23 | 9 | 2.43 | 56.60 | |
50 | Acta Pharmacologica Sinica | journal | 1.514 Q1 | 117 | 169 | 498 | 9324 | 2902 | 491 | 5.20 | 55.17 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®